Abstract:Many evidences indicate that oxidative stress plays a significant role in a variety of human disease states, including neurodegenerative diseases. Iron is an essential metal for almost all living organisms due to its involvement in a large number of iron-containing proteins and enzymes, though it could be also toxic. Actually, free iron excess generates oxidative stress, particularly in brain, where anti-oxidative defences are relatively low. Its accumulation in specific regions is associated with pathogenesis in a variety of neurodegenerative diseases (i.e., Parkinson’s disease, Alzheimer’s disease, Huntington’s chorea, Amyotrophic Lateral Sclerosis and Neurodegeneration with Brain Iron Accumulation). Anyway, the extent of toxicity is dictated, in part, by the localization of the iron complex within the cell (cytosolic, lysosomal and mitochondrial), its biochemical form, i.e., ferritin or hemosiderin, as well as the ability of the cell to prevent the generation and propagation of free radical by the wide range of antioxidants and cytoprotective enzymes in the cell. Particularly, ferrous iron can act as a catalyst in the Fenton reaction that potentiates oxygen toxicity by generating a wide range of free radical species, including hydroxyl radicals (·OH). The observation that patients with neurodegenerative diseases show a dramatic increase in their brain iron content, correlated with the production of reactive oxigen species in these areas of the brain, conceivably suggests that disturbances in brain iron homeostasis may contribute to the pathogenesis of these disorders. The aim of this review is to describe the chemical features of iron in human beings and iron induced toxicity in neurodegenerative diseases. Furthermore, the attention is focused on metal chelating drugs therapeutic strategies.

3-Hydroxy-3-methylglutaryl-CoA lyase (HL): gene targeting causes prenatal lethality in HL-deficient mice.

Heme in pathophysiology: a matter of scavenging, metabolism and trafficking across cell membranes

Heme in the Process of Bacterial Survival and Infection

Endoscopic removal of urinary calculi.

Heme Degradation in Pathophysiology of and Countermeasures to Inflammation-Associated Disease

Heme (dys)homeostasis and liver disease

Physiological and Pathological Functions of Neuronal Hemoglobin: A Key Underappreciated Protein in Parkinson’s Disease

Heme Oxygenase-1 as a Therapeutic Target in Neurodegenerative Diseases and Brain Infections

Heme in Cardiovascular Diseases: A Ubiquitous Dangerous Molecule Worthy of Vigilance

Iron imbalance in neurodegeneration

Oxidative stress and neurodegeneration: the involvement of iron

Heme homeostasis and its regulation by hemoproteins in bacteria

HEME: a neglected player in nociception?

Role of Heme Oxygenase as a Modulator of Heme-Mediated Pathways

The Multifaceted Role of Heme in Cancer

Heme Oxygenase-1 Signaling and Redox Homeostasis in Physiopathological Conditions

The sinister face of heme oxygenase-1 in brain aging and disease

Polymerase chain reaction-based mRNA quantification using an internal standard: analysis of oncogene expression.

Brain iron metabolism and its perturbation in neurological diseases

Update on heme biosynthesis, tissue‐specific regulation, heme transport, relation to iron metabolism and cellular energy

Regenerative Effects of Heme Oxygenase Metabolites on Neuroinflammatory Diseases